Why the study?
Is increased systemic immune-inflammation index associated with all-cause mortality in patients with ASCVD?
Is increased systemic immune-inflammation index associated with all-cause mortality in patients with ASCVD?
Answers are grounded in this paper and cite their sources.
The systemic immune-inflammation index may serve as a prognostic marker for survival in patients with arteriosclerotic cardiovascular disease.
An association was detected between the baseline ln-SII and all-cause mortality in a United States ASCVD population. Increased SII is associated with poor survival in individuals with ASCVD.
No takes yet. Share an insight, caveat, or question.
He et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: